| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.45B | +3.5% |
| Cost of Revenue | $206.6M | +3.1% |
| R&D Expense | $62.0M | -8.0% |
| SG&A Expense | $210.0M | +3.2% |
| Operating Income | $183.1M | +61.1% |
| Interest Expense | $37.6M | +6.5% |
| Pre-tax Income | $80.7M | -13.4% |
| Income Tax | $25.4M | -38.5% |
| Net Income | $47.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $607.0M | +20.0% |
| Accounts Receivable | $667.2M | +1.1% |
| Current Assets | $1.37B | +7.7% |
| Total Assets | $3.66B | -1.1% |
| Current Liabilities | $1.07B | +19.5% |
| Long-term Debt | $866.5M | +0.3% |
| Total Liabilities | $1.91B | +0.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $407.1M | +4.3% |
| Capital Expenditures | $119.2M | +11.8% |
| Investing Cash Flow | -$145.8M | +51.0% |
| Financing Cash Flow | -$170.3M | +46.9% |
| Free Cash Flow | $287.9M | +1.5% |
| -24.9% |
| EPS (Basic) | $1.16 | -18.3% |
| EPS (Diluted) | $1.15 | -19.0% |
| Stockholders' Equity |
| $1.75B |
| -3.2% |